• Luthvia Luthvia Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • Urip Harahap Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia
  • Syafrizal Nasution Hemodialysis Division, Department of Internal Medicine, Medical Faculty, University of Sumatera Utara/Haji Adam Malik General Hospital, Medan, Indonesia.



Anemia, Erythropoietin, DRPs, Hemoglobin, Hemodialysis


Objectives: This research aims to know the effect of drug-related problems (DRPs)-related doses against the target hemoglobin levels in hemodialysis (HD) patients in the regular phase of the correction given the therapy of erythropoietin on H. Adam Malik Medan.

Methods: This research was by the cross-sectional, prospective method, using DRP - Registration Form V7.0 (PCNE) against 50 patients. The data were analyzed statistically using Chi-square test, paired t-test sample, and independent t-test, SPSS version 17.

Results: The target hemoglobin not reaching 30 patients (60%), the level of hemoglobin target exceeded target 1 of the patients (2%). Based on the results of the test t, the value of p=0.038<0.05, then there is a difference in the level of hemoglobin after providing significant erythropoietin therapy between doses and less excess. Test the level of hemoglobin of erythropoietin therapy before and after using a test sample. Paired t-test based on the results, obtained significant value is 0.05, then 0.015< increased hemoglobin level after statistics are given significant therapy of erythropoietin.

Conclusion: The results of this study indicate that there is an effect of DRPs related to excessive dosage; less dose to target hemoglobin level with significant value, so DRPs-associated dose affect the target hemoglobin level.



Download data is not yet available.


Suwitra K. Chronic Kidney Disease. In the Internal Medicine Book. 5th ed. Jakarta: Internal Medicine, Department, Faculty of Medicine; 2009. p. 1035-7.

WHO. Hemoglobin Concentrations in the Diagnosis of Anemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization, (WHO/MNH/NHD/MNN/11.1); 2011.

Rsup H, Malik A. Hemodialysis Handbook. Indonesian: Field; 2015. p. 12.

Tapan E. Kidney Disease and Hypertension. Medan: PT. Elex Media

Komputindo; 2004.

Lee GR. The Normocytic Normochromic Anemias. In: Lee GR, Bithel TC, Foeater J, Athens J, Lukens JN, editors. Wintrobe Clinical Hematology. 9th ed., Vol. 1. London: Lea & Febringer; 1993.

The Indonesian Nephrology Association. Assessment of the Status of Iron and Iron Therapy. Consensus Management Anemia In Chronic Kidney Disease. 2nd ed. Indonesian: The Indonesian Nephrology Association; 2011. p. 11-6.

Elsayed AS, Azab AE. Correlation between chronic kidney diseases and hematological data in sabratha hospital in libya. Asian J Pharm Clin Res 2017;10:291-6.

Suhardjono A. Cardiovascular disorders in chronic kidney disease. Jakarta: Journal of Internal Medicine; 2009. p. 9-35.

National Kidney Foundation (NKF), Kidney Disease Outcome Quality Initiative (K/DOQI). Advisory Board. K/DOQI clinical practice guideline for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;17:19-28.

Sjamsiah S. Renal Failure Pharmacotheraphy. Surabaya: Universitas Airlangga; 2005. p. 214.

American. Society of Hospital Pharmacists. ASHP Statement on Pharmaceutical Care. Am J Hosp Pharm 1993;50:1720-3.

Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug related problems in an outpatient hemodialysis unit and impact of a clinical pharmacist. Clin Nephrol 1997;47:115-218.

Herlinawati AY, Saurisari R, Andrajat R. Influence of pharmacists’ intervention on drug-related problems related to change in hemoglobin levels of hemodialysis patients at adjidarmo hospital. Asian J Pharm Clin Res 2017;10:124-6.

Fitrah J. Identification of Drug Related Problems in Open Grade IIIA Fraktur IIIA Patients Treated in Antibiotics at Trauma Center. M. Djamil Padang. Thesis. Padang: University of Andalas; 2011.

Wulandari F, Arifin H, Darwin D. Analysis of Drug Related Problems in Patients with Dyspepsia in Inpatient and Outpatient Wards of Internal Medicine Dr. M. Djamil Padang; 2011. Available from: tesis- fennyl.pdf. [Last diakses on 2016 Sep 30].

Urip HS, dan Hasanul A. Prospective study effect of drug related problems (DRPs) reduction of drug effects on pain patients remover ward in post surgery ortopedi haji adam malik general hospitals in Medan. Int J Pharmtech Res 2013;8:189-92.

PCNE. Pharmaceutical Care Network Europe. Available from: -us.php. [Last retrieved on 2016 Aug 21].

Raosoft. Sample size calculator. Available from: size. [Last accessed on 2016 Jan 4].

Rsup H, Malik A. Hemodialysis Service Handbook. Medan: Field; 2016. p. 12.

Susalit E. Early Diagnosis of Chronic Kidney Disease. Jakarta: Journal of Internal Medicine; 2009. p. 9-12.

Wilson M. Chronic Kidney Failure. In: Price AS, Wilson ML, editors. Clinical Pathophysiology of Disease Processes. Jakarta: EGC; 1995.

Khairunnisa C, Hari Ronaldo T, Dadang Husori. Pharmacy Statistics Practicum Guide. Medan: USU Press; 2013. p. 84.



How to Cite

Luthvia, L., U. Harahap, and S. Nasution. “THE EFFECT OF ERYTHROPOIETIN DOSE PHASE OF CORRECTION AS DRUG-RELATED PROBLEMS TO TARGET LEVEL OF HEMOGLOBIN IN REGULAR HEMODIALYSIS PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 5, May 2018, pp. 151-4, doi:10.22159/ajpcr.2018.v11i5.24313.



Original Article(s)

Most read articles by the same author(s)

1 2 3 > >>